MDR Expression in Normal Tissues: Pharmocologic Implication for the Clinical Use of P-Glycoprotein Inhibitors
Open Access
- 1 April 1995
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 9 (2) , 319-336
- https://doi.org/10.1016/s0889-8588(18)30097-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Cholestatic steroid glucuronides: Interactions with P-glycoprotein (P-GP) . Department Pharmacology and College of Pharmacy, U Kentucky, Lexington, KYHepatology, 1993
- Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primatesHepatology, 1993
- Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cellsCancer Immunology, Immunotherapy, 1993
- Effect of Cyclosporine on Colchicine Secretion by A Liver Canalicular Transporter Studied In VivoHepatology, 1992
- New Mechanisms of Hormone Secretion: MDR-Like Gene Products as Extrusion Pumps for Hormones?Hormone and Metabolic Research, 1992
- Multidrug resistance gene family and chemical carcinogensPharmacology & Therapeutics, 1991
- Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cellsCell, 1991
- Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterusMolecular Reproduction and Development, 1990
- Coinduction of MDR-1 Multidrug-Resistance and Cytochrome P-450 Genes in Rat Liver by XenobioticsJNCI Journal of the National Cancer Institute, 1988
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987